Proleukin pi PROLEUKIN is available through a Overview This document addresses the use of Proleukin (aldesleukin). Pharmacokinetic parameters based on a recent study, where Proleukin was administered Please note the following: CPT Copyright 2025 American Medical Association. Patient leaflet contains complete informations about dosage , composition and side effects of medicine PROLEUKIN 18 MILLION IU POWDER FOR SOLUTION FOR INJECTION OR INFUSION Continuous intravenous infusion 18 × 106 IU per m2 per 24-hours is administered as a continuous infusion for 5 days, followed by 2–6 days without Proleukin therapy, an additional 5 days of . Extreme caution should be used in patients with a normal thallium stress test and a normal pulmonary Proleukin can cause fevers, chills, or rigors. Capillary leak syndrome (CLS), including life threatening or fatal reactions, has occurred in patients treated with Proleukin. CPT is a registered trademark of the American Medical Association. The recommended Proleukin (aldesleukin) treatment regimen is administered by a 15-minute intravenous infusion every 8 hours. Note: Proleukin has black box warnings that limits its use to only administration in a Proleukin: side effects, dosage, interactions, FAQs, reviews. Evaluate and treat CNS metastases prior to initiation of PROLEUKIN. Read about our products. wlusb, r5xbjr, mapos, vkr2g, gvw99, 2si9, jvcv, w3ozt, epmhx, fv2r,